Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samra Turajlic

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Pigment Cell & Melanoma Research|May 15, 2012
Genomic characterisation of acral melanoma cell linesSimon J Furney, Samra Turajlic, Kerry Fenwick, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Molecular Cancer Research : MCR|January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencingRichard Culliford, Charlie Mills, Daniel Chubb, et al.
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 14, 2023
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal studyMatthew R Orton, Evan Hann, Simon J Doran, et al.
Human Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Pigment Cell & Melanoma Research|May 15, 2012
Genomic characterisation of acral melanoma cell linesSimon J Furney, Samra Turajlic, Kerry Fenwick, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Molecular Cancer Research : MCR|January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencingRichard Culliford, Charlie Mills, Daniel Chubb, et al.
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 14, 2023
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal studyMatthew R Orton, Evan Hann, Simon J Doran, et al.
Human Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.
Pageof 13